Edvard Abel

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer

Maria Gebre‐Medhin, Eva Brun, Per Engström et al. · Journal of Clinical Oncology · 2020 · 177 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Long-Term Aspects of Quality of Life in Head and Neck Cancer Patients Treated With Intensity Modulated Radiation Therapy: A 5-Year Longitudinal Follow-up and Comparison with a Normal Population Cohort

Edvard Abel, Ewa Silander, Jan Nyman et al. · Advances in Radiation Oncology · 2019 · 43 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Impact on quality of life of IMRT versus 3-D conformal radiation therapy in head and neck cancer patients: A case control study

Edvard Abel, Ewa Silander, Jan Nyman et al. · Advances in Radiation Oncology · 2017 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Results of preoperative chemoradiotherapy for patients with advanced cancer of the nasal cavity and paranasal sinuses

Erik Fernström, Jan Nyman, Eva Hammerlid et al. · Acta Oto-Laryngologica · 2017 · 27 citations

Medicine, Oncology, Surgery +14